{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T12:24:58Z","timestamp":1763036698639,"version":"3.40.4"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2012,10,7]],"date-time":"2012-10-07T00:00:00Z","timestamp":1349568000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nervenarzt"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1007\/s00115-012-3645-z","type":"journal-article","created":{"date-parts":[[2012,10,5]],"date-time":"2012-10-05T17:54:19Z","timestamp":1349459659000},"page":"173-189","source":"Crossref","is-referenced-by-count":11,"title":["Vitamin\u00a0D und Multiple Sklerose","Vitamin\u00a0D and multiple sclerosis"],"prefix":"10.1007","volume":"84","author":[{"given":"A.","family":"D\u00f6ring","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Paul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"D\u00f6rr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,10,7]]},"reference":[{"key":"3645_CR1","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1056\/NEJM200009283431307","volume":"343","author":"Noseworthy","year":"2000","unstructured":"Noseworthy JH, Lucchinetti C, Rodriguez M et al (2000) Multiple scleroris. N Engl J Med 343:938\u2013952","journal-title":"N Engl J Med"},{"key":"3645_CR2","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1007\/s001150050559","volume":"71","author":"Hein","year":"2000","unstructured":"Hein T, Hopfenm\u00fcller W (2000) Projection of the number of multiple sclerosis patients in Germany. Nervenarzt 71:288\u2013294","journal-title":"Nervenarzt"},{"key":"3645_CR3","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/S0140-6736(08)61620-7","volume":"372","author":"Compston","year":"2008","unstructured":"Compston A, Coles A (2008) Multiple sclerosis. Lancet Neurol 372:1502\u20131517","journal-title":"Lancet Neurol"},{"key":"3645_CR4","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1007\/s00415-011-6101-2","volume":"258","author":"Buck","year":"2011","unstructured":"Buck D, Hemmer B (2011) Treatment of multiple sclerosis: current concepts and future perspectives. J Neurol 258:1747\u20131762","journal-title":"J Neurol"},{"key":"3645_CR5","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1007\/s00415-008-0061-1","volume":"255","author":"Multiple","year":"2008","unstructured":"Multiple Sclerosis Therapy Consensus Group (MSTCG), Wiendl H, Toyka KV, Rieckmann P et al (2008) Basic and escalating immunomodulatory treatments in multiple sclerosis: Current therapeutic recommendations. J Neurol 255:1449\u20131463","journal-title":"J Neurol"},{"key":"3645_CR6","doi-asserted-by":"crossref","unstructured":"Holick MF: Vitamin D: A millenium perspective. C Cell Biochem 2003; 88:296\u2013307","DOI":"10.1002\/jcb.10338"},{"key":"3645_CR7","doi-asserted-by":"crossref","unstructured":"Holick MF: Vitamin D deficiency. N Engl J Med 2007; 357:266\u2013281","DOI":"10.1056\/NEJMra070553"},{"key":"3645_CR8","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.autrev.2011.05.002","volume":"10","author":"Peelen","year":"2011","unstructured":"Peelen E, Knippenberg S, Muris A-Het al (2011) Effects of vitamin D on the peripheral adaptive immune system: a review. Autoimmun Rev 10:733\u2013743","journal-title":"Autoimmun Rev"},{"key":"3645_CR9","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1042\/BJ20110744","volume":"441","author":"Fleet","year":"2012","unstructured":"Fleet JC, DeSmet M, Johnson R, Li Y (2012) Vitamin D and cancer: a review of molecular mechanisms. Biochem J 441:61\u201376","journal-title":"Biochem J"},{"key":"3645_CR10","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.autrev.2010.06.009","volume":"9","author":"Souberbielle","year":"2010","unstructured":"Souberbielle J-C, Body J-J, Lappe JMet al (2010) Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: Recommendations for clinical practice. Autoimmun Rev 9:709\u2013715","journal-title":"Autoimmun Rev"},{"key":"3645_CR11","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S0031-6997(24)01468-6","volume":"52","author":"Falkenstein","year":"2000","unstructured":"Falkenstein E, Tillmann HC, Christ M et al (2000) Multiple actions of steroid hormones--a focus on rapid, nongenomic effects. Pharmacol Rev 52:513\u2013556","journal-title":"Pharmacol Rev"},{"key":"3645_CR12","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s00198-008-0626-y","volume":"20","author":"Hagenau","year":"2008","unstructured":"Hagenau T, Vest R, Gissel TN et al (2008) Global vitamin D levels in relation to age, gender, skin pigmentation and latitude: an ecologic meta-regression analysis. Osteoporos Int 20:133\u2013140","journal-title":"Osteoporos Int"},{"key":"3645_CR13","doi-asserted-by":"crossref","unstructured":"Vieth R (2004) Why the optimal requirement for Vitamin D3 is probably much higher than what is officially recommended for adults. J Steroid Biochem Mol Biol 89-90:575\u2013579","DOI":"10.1016\/j.jsbmb.2004.03.038"},{"key":"3645_CR14","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1055\/s-0028-1128131","volume":"41","author":"Reusch","year":"2009","unstructured":"Reusch J, Ackermann H, Badenhoop K (2009) Cyclic changes of vitamin D and PTH are primarily regulated by solar radiation: 5-year analysis of a German (50 degrees N) population. Horm Metab Res 41:402\u2013407","journal-title":"Horm Metab Res"},{"key":"3645_CR15","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1038\/sj.ejcn.1602825","volume":"62","author":"Hintzpeter","year":"2008","unstructured":"Hintzpeter B, Mensink GBM, Thierfelder W et al (2008) Vitamin D status and health correlates among German adults. Eur J Clin Nutr 62:1079\u20131089","journal-title":"Eur J Clin Nutr"},{"key":"3645_CR16","doi-asserted-by":"crossref","unstructured":"Fernandes de Abreu DA, Eyles D, F\u00e9ron F (2009) Vitamin D, a neuro-immunomodulator: implications for neurodegenerative and autoimmune diseases. Psychoneuroendocrinology.; 34 [Suppl 1]:265\u2013277","DOI":"10.1016\/j.psyneuen.2009.05.023"},{"key":"3645_CR17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pgen.1000369","volume":"5","author":"Ramagopalan","year":"2009","unstructured":"Ramagopalan SV, Maugeri NJ, Handunnetthi L et al (2009) Expression of the Multiple Sclerosis-Associated MHC Class II Allele HLA-DRB1*1501 Is Regulated by Vitamin D. PLoS Genet 5:1\u20136","journal-title":"PLoS Genet"},{"key":"3645_CR18","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nature10251","volume":"476","author":"Sawcer","year":"2011","unstructured":"Sawcer S, Hellenthal G, Pirinen Met al (2011) Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature 476:214\u2013219","journal-title":"Nature"},{"key":"3645_CR19","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1038\/ng.396","volume":"41","author":"Australia","year":"2009","unstructured":"Australia and New Zealand Multiple Sclerosis Genetics Consortium (ANZgene) (2009) Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20. Nat Genet 41:824-828","journal-title":"Nat Genet"},{"key":"3645_CR20","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1093\/brain\/awp033","volume":"132","author":"Correale","year":"2009","unstructured":"Correale J, Ysrraelit MC, Gait\u00e1n MI (2009) Immunomodulatory effects of Vitamin D in multiple sclerosis. Brain 132:1146\u20131160","journal-title":"Brain"},{"key":"3645_CR21","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1172\/JCI115072","volume":"87","author":"Lemire","year":"1991","unstructured":"Lemire JM, Archer DC (1991) 1,25-dihydroxyvitamin D3 prevents the in vivo induction of murine experimental autoimmune encephalomyelitis. J Clin Invest 87:1103\u20131107","journal-title":"J Clin Invest"},{"key":"3645_CR22","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.4049\/jimmunol.1002545","volume":"186","author":"Yu","year":"2011","unstructured":"Yu S, Cantorna MT (2011) Epigenetic reduction in invariant NKT cells following in utero vitamin D deficiency in mice. J Immunol 186:1384\u20131390","journal-title":"J Immunol"},{"key":"3645_CR23","doi-asserted-by":"crossref","first-page":"e6635","DOI":"10.1371\/journal.pone.0006635","volume":"4","author":"Smolders","year":"2009","unstructured":"Smolders J, Thewissen M, Peelen E et al (2009) Vitamin D Status Is Positively Correlated with Regulatory T Cell Function in Patients with Multiple Sclerosis. PLoS One 4:e6635","journal-title":"PLoS One"},{"key":"3645_CR24","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.4049\/jimmunol.179.3.1634","volume":"179","author":"Chen","year":"2007","unstructured":"Chen S, Sims GP, Chen XX et al (2007) Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation. J Immunol 179:1634\u20131647","journal-title":"J Immunol"},{"key":"3645_CR25","doi-asserted-by":"crossref","first-page":"7861","DOI":"10.1073\/pnas.93.15.7861","volume":"93","author":"Cantorna","year":"1996","unstructured":"Cantorna MT, Hayes CE, DeLuca HF (1996) 1,25-Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis. Proc Natl Acad Sci U S A 93:7861\u20137864","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3645_CR26","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1002\/jnr.21382","volume":"85","author":"Pedersen","year":"2007","unstructured":"Pedersen LB, Nashold FE, Spach KM, Hayes CE (2007) 1,25-dihydroxyvitamin D3 reverses experimental autoimmune encephalomyelitis by inhibiting chemokine synthesis and monocyte trafficking. J Neurosci Res 85:2480\u20132490","journal-title":"J Neurosci Res"},{"key":"3645_CR27","doi-asserted-by":"crossref","first-page":"e26262","DOI":"10.1371\/journal.pone.0026262","volume":"6","author":"Wergeland","year":"2011","unstructured":"Wergeland S, Torkildsen \u00d8, Myhr K-M et al (2011) Dietary vitamin D3 supplements reduce demyelination in the cuprizone model. PLoS One 6:e26262","journal-title":"PLoS One"},{"key":"3645_CR28","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jchemneu.2004.08.006","volume":"29","author":"Eyles","year":"2005","unstructured":"Eyles DW, Smith S, Kinobe R et al (2005) Distribution of the vitamin D receptor and 1 alpha-hydroxylase in human brain. J Chem Neuroanat 29:21\u201330","journal-title":"J Chem Neuroanat"},{"key":"3645_CR29","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S1043-2760(01)00547-1","volume":"13","author":"Garcion","year":"2002","unstructured":"Garcion E, Wion-Barbot N, Montero-Menei CN et al (2002) New clues about vitamin D functions in the nervous system. Trends Endocrinol Metab 13:100\u2013105","journal-title":"Trends Endocrinol Metab"},{"key":"3645_CR30","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/jnr.490280111","volume":"28","author":"Wion","year":"1991","unstructured":"Wion D, MacGrogan D, Neveu I et al (1991) 1,25-Dihydroxyvitamin D3 is a potent inducer of nerve growth factor synthesis. J Neurosci Res 28:110\u2013114","journal-title":"J Neurosci Res"},{"key":"3645_CR31","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1210\/en.138.1.12","volume":"138","author":"Musiol","year":"1997","unstructured":"Musiol IM, Feldman D (1997) 1,25-dihydroxyvitamin D3 induction of nerve growth factor in L929 mouse fibroblasts: effect of vitamin D receptor regulation and potency of vitamin D3 analogs. Endocrinology 138:12\u201318","journal-title":"Endocrinology"},{"key":"3645_CR32","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1097\/00001756-199412300-00032","volume":"6","author":"Neveu","year":"1994","unstructured":"Neveu I, Naveilhan P, Baudet C et al (1994) 1,25-dihydroxyvitamin D3 regulates NT-3, NT-4 but not BDNF mRNA in astrocytes. Neuroreport 6:124\u2013126","journal-title":"Neuroreport"},{"key":"3645_CR33","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0169-328X(02)00545-4","volume":"108","author":"Sanchez","year":"2002","unstructured":"Sanchez B, Lopez-Martin E, Segura C et al (2002) 1,25-Dihydroxyvitamin D(3) increases striatal GDNF mRNA and protein expression in adult rats. Brain Res Mol Brain Res 108:143\u2013146","journal-title":"Brain Res Mol Brain Res"},{"key":"3645_CR34","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1600-0404.1966.tb02008.x","volume":"42","author":"Kurtzke","year":"1966","unstructured":"Kurtzke JF (1966) An evaluation of the geographic distribution of multiple sclerosis. Acta Neurol Scand 42 (Suppl 19):91\u2013117","journal-title":"Acta Neurol Scand"},{"key":"3645_CR35","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/nri3045","volume":"11","author":"Hart","year":"2011","unstructured":"Hart PH, Gorman S, Finlay-Jones JJ (2011) Modulation of the immune system by UV radiation: more than just the effects of vitamin D? Nat Rev Immunol 11:584-596","journal-title":"Nat Rev Immunol"},{"key":"3645_CR36","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1136\/bmj.327.7410.316","volume":"327","author":"van","year":"2003","unstructured":"van der Mei IAF, Ponsonby A-L, Dwyer T et al (2003) Past exposure to sun, skin phenotype, and risk of multiple sclerosis: case-control study. BMJ 327:316","journal-title":"BMJ"},{"key":"3645_CR37","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1159\/000166602","volume":"31","author":"Tremlett","year":"2008","unstructured":"Tremlett H, van der Mei IAF, Pittas F et al (2008) Monthly ambient sunlight, infections and relapse rates in multiple sclerosis. Neuroepidemiology 31:271\u2013279","journal-title":"Neuroepidemiology"},{"key":"3645_CR38","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1212\/01.wnl.0000268266.50850.48","volume":"69","author":"Islam","year":"2007","unstructured":"Islam T, Gauderman WJ, Cozen W, Mack TM (2007) Childhood sun exposure influences risk of multiple sclerosis in monozygotic twins. Neurology 69:381\u2013388","journal-title":"Neurology"},{"key":"3645_CR39","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1177\/1352458510366856","volume":"16","author":"Dalmay","year":"2010","unstructured":"Dalmay F, Bhalla D, Nicoletti A et al (2010) Multiple sclerosis and solar exposure before the age of 15 years: case\u2014control study in Cuba, Martinique and Sicily. Mult Scler 16:899\u2013908","journal-title":"Mult Scler"},{"key":"3645_CR40","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1212\/01.WNL.0000101723.79681.38","volume":"62","author":"Munger","year":"2004","unstructured":"Munger KL, Zhang SM, O\u2019Reilly E et al (2004) Vitamin D intake and incidence of multiple sclerosis. Neurology 62:60\u201365","journal-title":"Neurology"},{"key":"3645_CR41","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1001\/jama.296.23.2832","volume":"296","author":"Munger","year":"2006","unstructured":"Munger KL, Levin LI, Hollis BW et al (2006) Serum 25-Hydroxyvitamin D Levels and Risk of Multiple Sclerosis. JAMA 296:2832\u20132838","journal-title":"JAMA"},{"key":"3645_CR42","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1002\/ana.22456","volume":"70","author":"Mirzaei","year":"2011","unstructured":"Mirzaei F, Michels KB, Munger K et al (2011) Gestational vitamin D and the risk of multiple sclerosis in offspring. Ann Neurol 70:30\u201340","journal-title":"Ann Neurol"},{"key":"3645_CR43","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1136\/bmj.38301.686030.63","volume":"330","author":"Willer","year":"2005","unstructured":"Willer CJ, Dyment DA, Sadovnick AD et al (2005)Timing of birth and risk of multiple sclerosis: population based study. BMJ 330:120\u2013120","journal-title":"BMJ"},{"key":"3645_CR44","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/s00415-005-0917-6","volume":"253","author":"Sotgiu","year":"2005","unstructured":"Sotgiu S, Pugliatti M, Sotgiu MA et al (2005)Seasonal fluctuation of multiple sclerosis births in Sardinia. J Neurol 253:38\u201344","journal-title":"J Neurol"},{"key":"3645_CR45","doi-asserted-by":"crossref","unstructured":"Salzer J, Svenningsson A, Sundstr\u00f6m P 2010 () Season of birth and multiple sclerosis in Sweden. Acta Neurol Scand 122:70\u201373","DOI":"10.1111\/j.1600-0404.2010.01396.x"},{"key":"3645_CR46","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0022-510X(00)00408-1","volume":"181","author":"Jin","year":"2000","unstructured":"Jin Y, de Pedro-Cuesta J, S\u00f6derstr\u00f6m M et al (2000)Seasonal patterns in optic neuritis and multiple sclerosis: a meta-analysis. J Neurol Sci 181:56\u201364","journal-title":"J Neurol Sci"},{"key":"3645_CR47","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1111\/j.1468-1331.2010.03318.x","volume":"18","author":"Handel","year":"2011","unstructured":"Handel AE, Disanto G, Jarvis L et al (2011)Seasonality of admissions with multiple sclerosis in Scotland. Eur J Neurol 18:1109\u20131111","journal-title":"Eur J Neurol"},{"key":"3645_CR48","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1191\/1352458505ms1157oa","volume":"11","author":"Soilu-H\u00e4nninen","year":"2005","unstructured":"Soilu-H\u00e4nninen M, Airas L, Mononen I et al (2005) 25-Hydroxyvitamin D levels in serum at the onset of multiple sclerosis. Mult Scler 11:266\u2013271","journal-title":"Mult Scler"},{"key":"3645_CR49","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1177\/1352458506072666","volume":"13","author":"Barnes","year":"2007","unstructured":"Barnes MS, Bonham MP, Robson PJ et al (2007) Assessment of 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D3 concentrations in male and female multiple sclerosis patients and control volunteers. Mult Scler 13:670\u2013672","journal-title":"Mult Scler"},{"key":"3645_CR50","unstructured":"Holm\u00f8y T, Lossius A, Gundersen TE et al (2011) Intrathecal levels of vitamin D and IgG in multiple sclerosis. Acta Neurol Scand. http:\/\/onlinelibrary.wiley.com. DOI\/10.1111\/j.1600-0404.2011.01577.x\/abstract (last accessed on 15 March 2012)"},{"key":"3645_CR51","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1177\/1352458509107008","volume":"15","author":"Holm\u00f8y","year":"2009","unstructured":"Holm\u00f8y T, Moen SM, Gundersen TA et al (2009) 25-Hydroxyvitamin D in cerebrospinal fluid during relapse and remission of multiple sclerosis. Mult Scler 15:1280\u20131285","journal-title":"Mult Scler"},{"key":"3645_CR52","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/ana.21972","volume":"67","author":"Mowry","year":"2010","unstructured":"Mowry EM, Krupp LB, Milazzo M et al (2010) Vitamin D status is associated with relapse rate in pediatric-onset multiple sclerosis. Ann Neurol 67:618\u2013624","journal-title":"Ann Neurol"},{"key":"3645_CR53","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/ana.22043","volume":"68","author":"Simpson","year":"2010","unstructured":"Simpson Jr. S, Taylor B, Blizzard L et al (2010) Higher 25-hydroxyvitamin D is associated with lower relapse risk in multiple sclerosis. Ann Neurol 68:193\u2013203","journal-title":"Ann Neurol"},{"key":"3645_CR54","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/1531-8249(200008)48:2<271::AID-ANA28>3.0.CO;2-O","volume":"48","author":"Embry","year":"2000","unstructured":"Embry AF, Snowdon LR, Vieth R (2000) Vitamin D and seasonal fluctuations of gadolinium-enhancing magnetic resonance imaging lesions in multiple sclerosis. Ann Neurol 48:271\u2013272","journal-title":"Ann Neurol"},{"key":"3645_CR55","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/1531-8249(200002)47:2<276::AID-ANA28>3.0.CO;2-1","volume":"47","author":"Auer","year":"2000","unstructured":"Auer DP, Schumann EM, K\u00fcmpfel T et al (2000) Seasonal fluctuations of gadolinium-enhancing magnetic resonance imaging lesions in multiple sclerosis. Ann Neurol 47:276\u2013277","journal-title":"Ann Neurol"},{"key":"3645_CR56","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0306-9877(86)90010-1","volume":"21","author":"Goldberg","year":"1986","unstructured":"Goldberg P, Fleming MC, Picard EH (1986) Multiple sclerosis: Decreased relapse rate through dietary supplementation with calcium, magnesium and vitamin D. Med Hypotheses 21:193\u2013200","journal-title":"Med Hypotheses"},{"key":"3645_CR57","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1093\/ajcn\/86.3.645","volume":"86","author":"Kimball","year":"2007","unstructured":"Kimball SM, Ursell MR, O\u2019Connor P, Vieth R (2007) Safety of vitamin D3 in adults with multiple sclerosis. Am J Clin Nutr 86:645\u2013651","journal-title":"Am J Clin Nutr"},{"key":"3645_CR58","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/S0165-5728(02)00396-X","volume":"134","author":"Mahon","year":"2003","unstructured":"Mahon B., Gordon S., Cruz J et al (2003) 1986Cytokine profile in patients with multiple sclerosis following vitamin D supplementation. J Neuroimmunol 134:128\u201332","journal-title":"J Neuroimmunol"},{"key":"3645_CR59","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1212\/WNL.0b013e3181e1cec2","volume":"74","author":"Burton","year":"2010","unstructured":"Burton JM, Kimball S, Vieth R et al (2010) A phase I\/II dose-escalation trial of vitamin D3 and calcium in multiple sclerosis (e\u2013Pub ahead of print)(LOE Classification). Neurology 74:1852\u20131859","journal-title":"Neurology"},{"key":"3645_CR60","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1212\/WNL.0b013e3182343274","volume":"77","author":"Stein","year":"2011","unstructured":"Stein MS, Liu Y, Gray OM et al (2011) A randomized trial of high-dose vitamin D2 in relapsing-remitting multiple sclerosis. Neurology 77:1611\u20131618","journal-title":"Neurology"},{"key":"3645_CR61","doi-asserted-by":"crossref","unstructured":"Soilu-H\u00e4nninen M, Aivo J, Lindstr\u00f6m B-M et al (2012) A randomised, double blind, placebo controlled trial with vitamin D3 as an add on treatment to interferon \u03b2-1b in patients with multiple sclerosis. J Neurol Neurosurg Psychiatry. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22362918 (last accessed on 15 March 2012)","DOI":"10.1136\/jnnp-2011-301876"},{"key":"3645_CR62","doi-asserted-by":"crossref","unstructured":"Kampman MT, Steffensen LH, Mellgren SI, J\u00f8rgensen L (2012) Effect of vitamin D3 supplementation on relapses, disease progression and measures of function in persons with multiple sclerosis: exploratory outcomes from a double-blind randomised controlled trial. Mult Scler. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22354743 (last accessed on 15 March 2012)","DOI":"10.1177\/1352458511434607"},{"key":"3645_CR63","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1136\/jnnp.2004.056499","volume":"76","author":"Wingerchuk","year":"2005","unstructured":"Wingerchuk D, Lesaux J, Rice G et al (2005) A pilot study of oral calcitriol (1,25-dihydroxyvitamin D3) for relapsing\u2013remitting multiple sclerosis. J Neurol Neurosurg Psychiatry 76:1294\u20131296","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"3645_CR64","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1093\/ajcn\/85.1.6","volume":"85","author":"Hathcock","year":"2007","unstructured":"Hathcock JN, Shao A, Vieth R, Heaney R (2007) Risk assessment for vitamin D. Am J Clin Nutr 85:6\u201318","journal-title":"Am J Clin Nutr"},{"key":"3645_CR65","first-page":"CD008422","volume":"12","author":"Jagannath","year":"2010","unstructured":"Jagannath VA, Fedorowicz Z, Asokan GV et al (2010) Vitamin D for the management of multiple sclerosis. Cochrane Database Syst Rev 12:CD008422","journal-title":"Cochrane Database Syst Rev"},{"key":"3645_CR66","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1745-6215-13-15","volume":"13","author":"Dorr","year":"2012","unstructured":"Dorr J, Ohlraun S, Skarabis H, Paul F (2012) Efficacy of Vitamin D Supplementation in Multiple Sclerosis (EVIDIMS Trial): study protocol for a randomized controlled trial. Trials 13:15","journal-title":"Trials"},{"key":"3645_CR67","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s00415-006-0395-5","volume":"254","author":"Kampman","year":"2007","unstructured":"Kampman MT, Wilsgaard T, Mellgreen SI (2007) Outdoor activities and diet in childhood and adolescence relate to MS risk above the Arctic Circle. J Neurol 254:471\u2013477","journal-title":"J Neurol"},{"key":"3645_CR68","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1177\/1352458508095920","volume":"15","author":"Kragt","year":"2009","unstructured":"Kragt J, van Amerongen B, Killestein J et al (2009) Higher levels of 25-hydroxyvitamin D are associated with a lower incidence of multiple sclerosis only in women. Mult Scler 15:9\u201315","journal-title":"Mult Scler"},{"key":"3645_CR69","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1177\/1352458509107008","volume":"15","author":"Holm\u00f8y","year":"2009","unstructured":"Holm\u00f8y T, Moen SM, Gundersen TA et al (2009) 25-hydroxyvitamin D in cerebrospinal fluid during relapse and remission of multiple sclerosis. Mult Scler 15:1280\u20131285","journal-title":"Mult Scler"},{"key":"3645_CR70","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1212\/WNL.0b013e31820af93d","volume":"76","author":"Lucas","year":"2011","unstructured":"Lucas RM, Ponsonby AL, Dear K et al (2011) Sun exposure and vitamin D are independent risk factors for CNS demyelination. Neurology 76:540\u2013548","journal-title":"Neurology"},{"key":"3645_CR71","doi-asserted-by":"crossref","first-page":"627","DOI":"10.3109\/08820139.2011.573041","volume":"40","author":"Mosayebi","year":"2011","unstructured":"Mosayebi G, Ghazavi A, Ghasami K et al (2011) Therapeutic effect of vitamin D3 in multiple sclerosis patients. Immunol Invest 40:627\u2013639","journal-title":"Immunol Invest"},{"key":"3645_CR72","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1212\/WNL.0b013e31825fdec7","volume":"79","author":"Runia","year":"2012","unstructured":"Runia TF, Hop WC, de Rijke YB et al (2012) Lower serum vitamin D levels are associated with a higher relapse risk in multiple sclerosis. Neurology 79:261\u2013266","journal-title":"Neurology"}],"container-title":["Der Nervenarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-012-3645-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00115-012-3645-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-012-3645-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T01:00:44Z","timestamp":1744246844000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00115-012-3645-z"}},"subtitle":["Der Stellenwert f\u00fcr das Erkrankungsrisiko und die Behandlung","The role for risk of disease and treatment"],"short-title":[],"issued":{"date-parts":[[2012,10,7]]},"references-count":72,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["3645"],"URL":"https:\/\/doi.org\/10.1007\/s00115-012-3645-z","relation":{},"ISSN":["0028-2804","1433-0407"],"issn-type":[{"type":"print","value":"0028-2804"},{"type":"electronic","value":"1433-0407"}],"subject":[],"published":{"date-parts":[[2012,10,7]]}}}